Delayed treatment with nirmatrelvir/ritonavir could remain effective in patients with Omicron BA2.2 variant of COVID-19.

IF 5.2 4区医学 Q2 Medicine

Annals Academy of Medicine Singapore Pub Date : 2023-03-30 DOI:10.47102/annals-acadmedsg.2022453

Wenjie Wang, Jing Wan, Wei Du, Jing Song, Ye Lu, Shuiming Gu, Yunhai Feng, Gang Wang, Minfang Tao, Jun Yin

引用次数: 0

查看原文本刊更多论文

尼马特利韦/利托那韦延迟治疗对Omicron BA2.2变体COVID-19患者可能仍然有效

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals Academy of Medicine Singapore 医学-医学：内科

CiteScore

4.90

自引率

5.80%

发文量

186

审稿时长

6-12 weeks

期刊介绍： The Annals is the official journal of the Academy of Medicine, Singapore. Established in 1972, Annals is the leading medical journal in Singapore which aims to publish novel findings from clinical research as well as medical practices that can benefit the medical community.

文献相关原料

公司名称	产品信息	采购帮参考价格